RU2015154022A3 - - Google Patents

Download PDF

Info

Publication number
RU2015154022A3
RU2015154022A3 RU2015154022A RU2015154022A RU2015154022A3 RU 2015154022 A3 RU2015154022 A3 RU 2015154022A3 RU 2015154022 A RU2015154022 A RU 2015154022A RU 2015154022 A RU2015154022 A RU 2015154022A RU 2015154022 A3 RU2015154022 A3 RU 2015154022A3
Authority
RU
Russia
Application number
RU2015154022A
Other languages
Russian (ru)
Other versions
RU2015154022A (en
RU2669558C2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2015154022A publication Critical patent/RU2015154022A/en
Publication of RU2015154022A3 publication Critical patent/RU2015154022A3/ru
Application granted granted Critical
Publication of RU2669558C2 publication Critical patent/RU2669558C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2015154022A 2013-06-06 2014-05-27 Ophthalmic composition for zwitterionic soft contact lenses RU2669558C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013119946 2013-06-06
JP2013-119946 2013-06-06
PCT/JP2014/063961 WO2014196412A1 (en) 2013-06-06 2014-05-27 Ophthalmic composition for zwitterionic soft contact lens

Publications (3)

Publication Number Publication Date
RU2015154022A RU2015154022A (en) 2017-07-14
RU2015154022A3 true RU2015154022A3 (en) 2018-03-14
RU2669558C2 RU2669558C2 (en) 2018-10-12

Family

ID=52008062

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015154022A RU2669558C2 (en) 2013-06-06 2014-05-27 Ophthalmic composition for zwitterionic soft contact lenses

Country Status (6)

Country Link
JP (1) JP6366583B2 (en)
CN (1) CN105283183B (en)
HK (1) HK1217902A1 (en)
RU (1) RU2669558C2 (en)
TW (1) TWI626060B (en)
WO (1) WO2014196412A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346594B1 (en) * 1998-09-21 2002-02-12 Menicon Co., Ltd. Ocular lens material and process for producing same
JP4789479B2 (en) * 2004-02-23 2011-10-12 ロート製薬株式会社 Planoprofen-containing aqueous composition
JP2005247795A (en) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd Stable eye drops
JP4958401B2 (en) * 2004-12-28 2012-06-20 ロート製薬株式会社 Planoprofen-containing composition
JP4919666B2 (en) * 2005-01-26 2012-04-18 ロート製薬株式会社 Planoprofen-containing composition
JP5196130B2 (en) * 2005-12-27 2013-05-15 ライオン株式会社 Soft contact lens composition and adsorption suppression method
JP2008024701A (en) * 2006-06-21 2008-02-07 Rohto Pharmaceut Co Ltd Composition for soft contact lens comprising alginic acid or salt thereof
JP6009141B2 (en) * 2009-10-09 2016-10-19 ロート製薬株式会社 Aqueous composition
JP5846716B2 (en) * 2009-10-15 2016-01-20 ロート製薬株式会社 Ophthalmic composition for soft contact lenses
JP5909152B2 (en) * 2011-06-02 2016-04-26 ロート製薬株式会社 Aqueous composition containing tranilast

Also Published As

Publication number Publication date
WO2014196412A1 (en) 2014-12-11
CN105283183B (en) 2018-08-24
TW201534351A (en) 2015-09-16
RU2015154022A (en) 2017-07-14
TWI626060B (en) 2018-06-11
CN105283183A (en) 2016-01-27
HK1217902A1 (en) 2017-01-27
JPWO2014196412A1 (en) 2017-02-23
RU2669558C2 (en) 2018-10-12
JP6366583B2 (en) 2018-08-01

Similar Documents

Publication Publication Date Title
AP2016009275A0 (en)
BR112016011191A2 (en)
BR112015007533A2 (en)
BR102016010778A2 (en)
BR112014017733A2 (en)
BR112014017739A2 (en)
BR112016001534A2 (en)
BR112016008925A2 (en)
BR112014020341A2 (en)
BR112014017765A2 (en)
BR112014017669A2 (en)
BR112014021878A2 (en)
BR112016011370A2 (en)
BR112014017901A2 (en)
BR112015015948A2 (en)
BR112014017722A2 (en)
BR112014017653A2 (en)
BR112014017794A2 (en)
BR112016004709A2 (en)
BR112014017601A2 (en)
BR112015015312A2 (en)
BR112014017745A2 (en)
BR112014024039A2 (en)
BR112016000259A2 (en)
BR112016010078A2 (en)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20200528